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Abstract
Protein phosphorylation is a reversible post-translational modification essential for the regulation of several signal
transduction pathways and biological processes in the living cell. Therefore, the identification of protein phosphorylation
sites is crucial to understand cell signaling control at the molecular level. Based on mass spectrometry, recent studies have
reported the large-scale mapping of phosphorylation sites in various eukaryotes and prokaryotes. However, little is known
about the impact of phosphorylation in protozoan parasites. To in depth characterize the phosphoproteome of
Trypanosoma cruzi, a parasite of the Kinetoplastida class, protein samples from cells at different phases of the
metacyclogenesis – differentiation process of the parasites from non-infective epimastigotes to infective metacyclic
trypomastigotes - were enriched for phosphopeptides using TiO2 chromatography and analyzed on an LTQ-Orbitrap mass
spectrometer. In total, 1,671 proteins were identified, including 753 phosphoproteins, containing a total of 2,572
phosphorylation sites. The distribution of phosphorylated residues was 2,162 (84.1%) on serine, 384 (14.9%) on threonine
and 26 (1.0%) on tyrosine. Here, we also report several consensus phosphorylation sequence motifs and as some of these
conserved groups have enriched biological functions, we can infer the regulation by protein kinases of this functions. To our
knowledge, our phosphoproteome is the most comprehensive dataset identified until now for Kinetoplastida species. Here
we also were able to extract biological information and infer groups of sites phosphorylated by the same protein kinase. To
make our data accessible to the scientific community, we uploaded our study to the data repositories PHOSIDA, Proteome
Commons and TriTrypDB enabling researchers to access information about the phosphorylation sites identified here.
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Introduction
T. cruzi is the causal agent of Chagas disease, which has an
infection prevalence estimated at 15 million cases [1], and affects
neglected impoverished people primarily in Latin America, where
it is mostly transmitted to humans by the triatomine insects.
However, in the past decades, Chagas disease has been
increasingly detected in the United States of America, Canada,
many European and some Western Pacific countries, too. These
occurrences are mainly caused by population mobility between
Latin America and the rest of the world, infection through blood
transfusion, vertical transmission (from infected mother to child) or
organ donation (WHO 2010). The disease starts with an acute
infection, which can be lethal in few cases, but usually evolves into
a chronic stage that could lead to severe cardiopathy and
ultimately to death. Once the infection takes place, the treatment
is limited and the drugs currently available are highly toxic.
Four T. cruzi developmental stages have been well character-
ized, being two in the insect vector (epimastigotes and metacyclic
trypomastigotes) and two in the mammalian hosts (amastigotes
and bloodstream trypomastigotes) [2]. Epimastigotes and amasti-
gotes are the non-infective, replicative forms, whereas metacyclic
trypomastigotes and bloodstream trypomastigotes are the infective,
non-replicative forms. Metacyclogenesis is the process by which
epimastigotes differentiate into metacyclic trypomastigotes and
acquire infectivity in the digestive tract of the insect vector. This
process can be mimicked in vitro by cultivating epimastigotes
under chemically defined conditions [3], making it possible to
obtain intermediate differentiation forms as well as fully
differentiated metacyclic trypomastigotes.
The adaptation to distinct environments (e.g. the insect’s
digestive tract and the interior of mammalian cells), with different
temperatures, nutrient availability and immune response, requires
major changes in the parasites’ metabolism and gene expression. It
is known that Kinetoplastida lack several transcriptional control
mechanisms [4,5,6], giving post-transcriptional regulation a major
role in controlling their gene expression [7,8,9,10,11]. In addition,
there are also other dynamic control mechanisms, such as protein
post-translational modifications, that still need to be better
characterized in these organisms.
Protein phosphorylation is a reversible post-translational modi-
fication that constitutes a key mechanism to controlprotein function
via their activation/inactivation or change in sub cellular
localization. It regulates many physiological processes, including
metabolic pathways, gene transcription, membrane transport, and
cell division. Due to its importance in the control of signal
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crucial to the understanding of cell signaling control at the
molecular level. The relatively large number of protein kinase and
phosphatase encoding genes and the importance of post-transcrip-
tional control in protozoan parasites points to a fundamental role of
protein phosphorylation in these unicellular organisms.
Different approaches have been applied to search for phos-
phorylated proteins on Kinetoplastida parasites. However, due to
technical limitations, only few have been initially identified,
including RNA polymerase II [12] and the Acidic ribosomal P
proteins [13]. When it comes to identifying phosphorylation sites
with traditional approaches, still just a few examples (e.g. Serine 12
on Histone H1 for T. cruzi) [14] were described for Kinetoplastida.
Recently, new sample preparation strategies [15,16,17,18] and
mass spectrometry-based methodologies [19,20] have been devel-
oped to study protein phosphorylation, giving origin to the field of
phosphoproteomics. Thus, thousands of phosphorylation sites can
be identified, quantified and have their exact position determined in
a given experiment, clearly opening new perspectives on cell
signaling research. Despite these advances, however, only a few
large-scale phosphoproteomic studies have been performed in
Kinetoplastida so far, and the number of phosphoproteins and
phosphorylation sites described in the literature is very limited. In a
recent study Morales and co-workers identified 221 phosphorylated
proteins on Leishmania donovani, using phosphoprotein enrichment
andtwo-dimensional electrophoresisseparation followed bytandem
time-of-flight peptide sequencing [21]. With a combination of
strong cation-exchange (SCX) fractionation, titanium dioxide
(TiO2) chromatography phosphopeptide enrichment, and two
different hybrid mass spectrometers, Nett and co-workers identified
491 phosphoproteins and 1,204 phosphorylation sites on blood-
stream forms of T. brucei [22], Nett and co-workers also performed
an elegant work direct to identify and localize tyrosines phosphor-
ylated proteins [23]. Using a similar approach, Nakayasu and co-
workers combined SCX fractionation, ion metal-affinity chroma-
tography (IMAC) phosphopeptide enrichment on a low-resolution
mass spectrometer to identify 119 phosphorylated proteins and a
total of 192 unambiguous phosphorylation sites on epimastigote
forms of T. cruzi [24].
Here, to obtain a more comprehensive picture of the T. cruzi
phosphoproteome, we analyzed protein samples from parasites at
five different moments of differentiation during the process of
metacyclogenesis. The samples were enriched for phosphopeptides
applying TiO2 chromatography, analyzed by high-accuracy mass
spectrometry on a hybrid linear ion trap quadrupole–Orbitrap
instrument (LTQ-Orbitrap, Thermo Scientific), and advanced
bioinformatic tools were used to achieve unambiguous identification
and site-specific localization of protein phosphorylation sites [25,26].
We report the identification of several hundreds of phosphorylated
proteins and more than two thousand phosphorylation sites.
Additional bioinformatic analyses performed found structural
constraints and evolutionary conservation of the phosphorylation
sites reported here. In addition, insights into biological processes
regulated by phosphorylation could be inferred by the phosphor-
ylation enrichment of proteins involved on cytoskeleton dynamic
and protein kinase activity. Our study represents the most
comprehensive phosphoproteomics dataset available for any of
the Kinetoplastida parasites so far.
Results and Discussion
Profiling the Trypanosoma cruzi phosphoproteome
To increase the coverage of the phosphoproteome, we analyzed
cells from parasites at five different time points during the
differentiation process through which the parasite acquires
infectivity (metacyclogenesis). To enhance the sampling of
phosphorylated peptides we performed three sequential TiO2
enrichment steps for each sample. For better fragmentation of the
phosphopeptides, MS/MS were acquired using multi-stage
activation (MSA), also known as ‘‘pseudo-MS3’’ [20]. This
strategy was repeated in the same way for 3 biological replicates,
except for the fact that in the first biological replicate one of the
time points (adhered 12 hours) was not present, resulting in a total
of 42 LC-MS/MS runs for the complete experiment. The
identification of phosphoproteins and phosphosites was based on
the MaxQuant software [26].
Altogether, 130,459 MS/MS spectra were identified, corre-
sponding to 5,513 non-redundant peptide sequences. The high-
resolution data from the LTQ-Orbitrap mass spectrometer,
combined with innovative computational strategies (MaxQuant),
resulted in very high peptide mass accuracy for the precursor ions
(average absolute mass deviation of 362 p.p.b.), which contributed
considerably to the number and reliability of the identifications. A
total of 1,671 protein groups were identified (Table S1), among
which 753 were phosphorylated. For those phosphoproteins, 1,494
non-redundant phosphorylated peptides were determined. Some
of the phosphopeptides were detected in more than one
phosphorylation state (e.g. one, two, three phospho-groups) and,
after removing this redundancy, 2,572 distinct phosphorylation
sites presented a PTM score higher than 0.75 and a delta score
higher than 5 (Table S2), indicating that their position could be
determined with high confidence These phosphosites were used
for the subsequent analysis.
To estimate the contribution of our data to the literature, we
compared our phosphorylation sites with those previously
described. To our knowledge, there has been only one
phosphoproteomic study describing site-specific phosphorylation
events for T. cruzi, performed by Nakayasu and co-workers, which
analyzes only epimastigotes forms of the parasite and describes 192
unambiguous phosphorylation sites on 119 phosphorylated
proteins [24]. For a direct comparison with this data, we
considered only the phosphorylation sites detected in our study
for the epimastigote form of T. cruzi and found that 1,511
phosphorylation sites were novel. Overall, 2,523 sites were new,
resulting on a total of 2,715 phosphorylation sites described for T.
cruzi. This represents an increase of more than 13-fold in the total
number of phosphosites currently available for T. cruzi, making the
present work also the largest dataset generated for any of the
Kinetoplastida parasites. In addition, this is the only phosphopro-
teomics study to sample different life forms of the parasite so far.
Although the number of sites identified in our work is higher
than the one from the previous study, the overlap between the two
datasets is relatively low. This could be explained by several
experimental differences existing between the two studies, such as
the use of different T. cruzi strains, phosphopeptide enrichment
approaches [18], mass spectrometry platforms and validation
criteria for identification and localization of the phosphorylation
sites.
Structural constraints and conservation of
phosphorylation sites
We derived secondary structure and accessibility constraints to
phosphorylation sites using the prediction method SABLE 2.0
[27]. SABLE assigns the predicted secondary structure (helix, b-
sheet, or turn/loop) to each residue of a given protein sequence. In
addition, it calculates accessibility values ranging from 0 (fully
buried) to 9 (fully exposed). As in other eukaryotic phosphopro-
teomes [25,28], phosphorylation sites are almost exclusively
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In total, 83% of phosphorylated serines were predicted to be
located in non-regularly structured regions in comparison to 67%
of the serines that were not identified to be phosphorylated on the
same proteins (p,10
250 based on Chi Square Statistics). In
concordance, the predicted accessibilities were also significantly
higher for phosphorylated residues compared to their non-
phosphorylated counterpart (p,10
223 based on t statistics) (Figure
S2). These structural constraints are essential for kinase/
phosphatase substrate accessibility, as well as for subsequent
functional and structural effects on the substrate protein.
Based on two-directional BLASTP applications [29,30], we
derived homologs of the whole T. cruzi proteome in all domains of
life (Figure S3). Interestingly, the proportion of phosphorylated T.
cruzi proteins that have homologs in eukaryotic species is
significantly higher than the proportion of non-phosphorylated
T. cruzi proteins that show homologous counterparts in other
eukaryotic species. However, in the prokaryotic domain, phos-
phorylated T. cruzi proteins are as conserved as non-phosphory-
lated T. cruzi proteins.
Distribution of phosphorylation sites
The distribution of phosphorylation events in number of sites
per protein and peptide is illustrated in Figure S4. When
considering the categories individually, although the highest
number of phosphoproteins was found to have just one
phosphorylation site, if the phosphoproteome is considered as a
whole, the majority of phosphorylated proteins had multiple
phosphorylation sites: 73% having more than two and 53% having
three or more phosphorylation sites (Figure S4). Similarly, the
majority of non-redundant phosphopeptide sequences contained
multiple phosphorylation sites, despite the fact that the most
prominent individual class corresponded to singly phosphorylated
peptides. Likewise, most of the MS/MS spectra identified
belonged to multiply phosphorylated peptides. The most fre-
quently class identified (as estimated by spectra count) was the one
of doubly phosphorylated peptides, which accounted for more
than 35% of the total identified MS/MS (Figure S5), this could be
a biological characteristic or technical conditions such as TiO2
enrichment.
The S/T/Y distribution of the phosphorylated sites identified
by our work for T. cruzi mapped to 2,162 pS (84.1%)/384 pT
(14.9%)/26 pY (1.0%) amino acid residues. Although dedicated
tyrosine protein kinases (PKs) are still unknown, the occurrence of
tyrosine phosphorylation has been well reported in trypanosoma-
tids [23,31]. In this work, a total of 25 proteins were revealed to be
tyrosine phosphorylated, and 26 pY sites were exactly located
(Table S2). Tyrosine phosphorylation is known to play a key role
in cell signaling, and in our dataset different classes of proteins,
such as calpain-like cysteine peptidase, leucine-rich repeat protein
and several protein kinases were found to be phosphorylated on
tyrosine residues. The group of protein kinases (further discussed
below) is of particular interest, and accounted for more than 30%
of the phosphotyrosine sites identified in our dataset.
The kinome phosphoproteome
The completion of the genome sequence of the three model
trypanosomatids, T. brucei [32], T. cruzi [33,34] and L. major [35],
made possible to exploit these data to better understand important
protein groups of these parasites. Parsons and co-workers analyzed
the components of the kinome and described 179, 156, and 171
eukaryotic protein kinases (ePKs) and 17, 20, 19 atypical PKs
(aPKs) for L. major, T. brucei and T. cruzi, respectively [36]. The
number of PKs for the trypanosomatids is considerably larger than
that described for another intracellular parasite, Plasmodium
falciparum, which possesses 65 ePKs and 20 ePK-related sequences
[37]. In addition, for some PK families the gene number is
proportionally higher than Homo sapiens [38].
Despite the fact that a kinase-selective enrichment approach
[39] was not used, 42 phosphorylated protein kinases were
identified in our analysis, corresponding to a total of 125
phosphorylation sites (Table S3). Considering that T. cruzi contains
171 ePK/19 aPK in total [36], our dataset shows evidence of
phosphorylation for about 22% of the kinome, covering different
kinase families (Table 1).
Another interesting consideration is that, as mentioned above,
more than 30% of the phosphorylated tyrosines detected were
found on protein kinases. In addition, the T. cruzi kinome has the
S/T/Y phosphorylation sites distribution shifted towards the
phosphotyrosines (6% of all the phosphorylation sites found on
PKs are pYs), showing a 6-fold enrichment compared to the rate
found for the total phosphoproteome.
Parsons and colleagues [36] propose that the tyrosine
phosphorylation activity in trypanosomatids is likely to be due to
the action of atypical tyrosine kinases such as Wee1 and dual-
specificity tyrosine phosphorylation–regulated kinases (DYRKs),
that can also phosphorylate serine/threonine and tyrosine
residues. At the cellular level, they have been described as
regulators of differentiation, cell cycle progression, and apoptosis.
All DYRKs autophosphorylate a critical tyrosine in their
activation loop, but phosphorylate their substrates on serines or
threonines, which could be the explanation for the phosphorylated
tyrosine of the Trypanosoma cruzi DYRK (Tc00.10470535
11249.60). This could also be an example of autophosphorylation
events found in T. cruzi.
Phosphorylation in the activation loop segment, which repre-
sents a conserved structural element within the protein kinase
domain, has been implicated in the stabilization of the catalytically
active state of many eukaryotic protein kinases [40]. Phosphory-
lation at the activation loop was identified in 13 protein kinases,
belonging to seven different families: (i) five mitogen-activated
protein kinases (MAPKs); (ii) two RCKs and (iii) one CDKL - both
families similar to MAPKs; (iv) two CAMKL; (v) one PKA; (vi) one
NEK and (vii) one glycogen synthase protein kinase (GSK)
(Figure 1). Therefore, the presence of phosphorylation on the
activation loop, described here, could be a sign of activity
regulation of these kinases. The glycogen synthase kinases are
constitutively phosphorylated on a tyrosine residue in their
activation loop, which is required for their full enzymatic activity.
As previously described [24], for GSK we also identify tyrosine
187 phosphorylated, which is located, at its activation loop,
suggesting its auto-activation. In addition, we found evidence of
activation for 6 of the 15 described T. cruzi MAPK or MAPK-like
kinases, as demonstrated by the concomitant presence of both
tyrosine and threonine phosphorylation on their activation loop,
similar to what was previously described for T. brucei [22].
Although the identification of protein kinases responsible for
tyrosine phosphorylation in TriTryps is still missing, the
identification of phosphorylated tyrosines at the activation loop
of protein kinases reveals some phosphorylated tyrosine regulated
PKs.
Functional characterization of the T. cruzi
phosphoproteome
Intending to determine the biological processes correlating
genes with Gene Ontology (GO) terms that share common
biological aspects affected/regulated by protein phosphorylation
during the T. cruzi metacyclogenesis, the phosphorylated proteins
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T. cruzi gene set (see Material and methods section), to search for
differential GO representation (Table 2).
Eight functional groups were overrepresented at the phosphor-
ylated proteins compared to the genome. Interestingly, some
members of this group are related to the major morphological
changes correlated with modifications that happen during the
metacyclogenesis, since there is a change at the cell shape and at
the positioning of cellular organelles during the parasite’s
differentiation. Finding terms as cytoskeleton and cilium reinforces
the importance of this approach to identify key regulators of
biological processes. The enrichment of both terms is supported by
the localization of phosphorylated proteins at the flagellum [23], as
well as protein kinases related to roles in the movement of
organelles and cell division [41,42,43].
The protein kinases are effectors of signal transduction
pathways and can also be regulated by phosphorylation. The
discovery of ‘‘protein kinase activity’’ and ‘‘signal transduction’’
GO terms that were overrepresented at phosphorylated proteins
supports this idea. As the PKs trigger a wide range of processes,
they have to be tightly regulated. Moreover, the members of the
kinome also regulate each other’s function trough phosphoryla-
tion. For example, some kinases contain specific phosphorylation
sites within the activation loop that are important for determining
the conformation of the loop and, consequently, the activity of the
phosphorylated kinase [40]. This result is reinforced by the
identification of phosphorylation at the activation loop of several
protein kinases. Both evidences demonstrate the phosphorylation
control of this key regulatory function. The other overrepresented
GO terms found (Amino acid and derivative metabolic process;
Protein modification process; Nucleotide binding; Calcium ion
binding) are good candidates for better characterization of key
processes regulated by phosphorylation during this cellular
differentiation.
Phosphorylation Motifs
The number of phosphorylation sites revealed now for
trypanosomes can assist classical characterization of proteins and
pathways. Even though there is still a lack of information to
correlate the phosphorylation sites to protein kinases, here we
group similar phosphorylation sites that could be phosphorylated
by a specific protein kinase or few protein kinases that share the
same amino acids specificity at their substrates. This results on
groups of phosphorylation sites that regulate similar biological
functions being phosphorylated by a protein kinase that has
affinity by the motif present on these sites. To initially address the
issue of which kinases are the effectors of the identified
phosphorylation sites, an approach that could give us motifs of
phosphorylation sites was used. Using Motif-X [44], The
conservation of the amino acids close to the phospho amino acid
was used to extract patterns from our results, revealing
phosphorylation motifs.
Table 1. Phosphorylated protein kinases.
ePK/aPK Family Sub-Family Members Phosphoproteins
















CDKL (MAPK-like) 1 1
MAPK 11 5
RCK (MAPK-like) 3 2
SRPK 2 1
TOTAL 42 13
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acids) (Figure 2) for both S/T phosphorylation sites, 248 motifs
have been identified (Table S4). Although redundancy is apparent,
redundant motifs are formed not only by a similar core of sites but
also by different ones, as each window size presents different
situations of motif extraction.
Despite the absence of a direct link between the substrate and
the protein kinase we could group the phosphorylation sites based
on similar amino acid sequences surrounding the phospho amino
acid. Twenty-four different motifs were found using 19 amino
acids as window size, the bigger motif set found.
The results obtained from the enrichment analysis points to the
regulation of specific biological functions by protein kinases. To
map the predominant functional themes of each motif in order to
search for a similar biological regulation, we used statistical
analysis to test the overrepresentation of GO terms in the different
sets of motifs containing proteins present compared to the
population set (GO annotated T. cruzi MCL), through the
Blast2GO software [45].
This result can give some clues about the group of phosphor-
ylated proteins found with meaningful related motifs, as this
represents a group of proteins with similar biological properties
regulated by a Protein kinase. Here we show the GO enrichment
of six phosphorylation motifs (Figure 3): 1) RxxpSxS (motor
activity), 2) RxxSxxpS (motor activity, cytoskeleton and cytoskel-
eton organization and biogenesis), 3) pSxS (kinase activity and
cytoskeleton), 4) pSxxG (calcium ion binding), 5) SxxpS (protein
kinase activity) and 6) pTxxxxxxxxR (protein kinase activity,
protein modification process, amino acid and derivative metabolic
process, signal transduction, nucleotide binding, embryonic
development and reproduction). These motifs (and the proteins
correlated) can infer key regulated proteins for further character-
izations.
Thus, this work can greatly contribute to improve the
knowledge about trypanosomatids’ biology, helping to understand
key regulatory signal transduction events at the molecular level.
Even though this work gave interesting information and greatly
increased the number of phosphorylation sites known, further
quantitative and protein kinase-related substrate approaches are
still needed to clarify the regulated pathways more dynamically to
help understand the complex biological puzzle.
Phosphoproteome dynamics during T. cruzi
metacyclogenesis
The phosphorylation dataset described and characterized here
was obtained from 5 time points during the T. cruzi metacyclogen-
esis differentiation process. To start digging the proteins that may
be regulated during cellular differentiation, we chose to look for
processes/functions/components (GO terms) overrepresented at
each time point (Table 3).
All the time points showed enrichment for calcium ion binding,
protein kinase activity and protein modification process, meaning
that the proteins involved in all these functions/processes are
constantly being phosphorylated. Towards the late phases (Ad12h
and Meta), however, three new biological functions arised as
overrepresented: Cytoskeleton, motor activity and nucleotide
Figure 1. Kinases with phosphorylated activation loop. Blue boxes represent the conserved regions. Red line at the bottom represents the
activation region, with the non-organized activation loop in between the two conserved regions. The identified phosphorylation sites are highlighted
in green.
doi:10.1371/journal.pone.0025381.g001
Table 2. GO enrichment analysis of phosphorylated proteins.
GO Term GO Name FDR # Ph # Genome X
GO:0004672 protein kinase activity 2.06E-07 42 298 3.17
GO:0006464 protein modification process 1.26E-05 59 609 2.21
GO:0005509 calcium ion binding 4.36E-05 16 75 4.50
GO:0006519 amino acid and derivative metabolic process 5.05E-04 45 488 2.03
GO:0000166 nucleotide binding 1.04E-02 85 1258 1.52
GO:0005856 Cytoskeleton 1.63E-02 23 237 2.04
GO:0007165 signal transduction 2.67E-02 23 249 1.94
GO:0005929 Cilium 3.02E-02 5 20 5.11
FDR, False Discovery Rate; # Ph, number of phosphorylated proteins; # Genome, number of proteins present in the genome; X, enrichment of each GO term.
doi:10.1371/journal.pone.0025381.t002
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protein phosphorylation, specifically at the end of metacyclogen-
esis, could indicate the key regulated molecules responsible for the
morphological changes that give origin to metacyclic trypomas-
tigotes. The nucleotide binding function, although too general,
could indicate that RNA binding proteins and cyclic nucleotide
binding proteins are also being regulated at the late stages of
differentiation.
Despite the fact that the data is not really quantitative, as our
experimental design is a time point situation across T. cruzi
differentiation, it was interesting to observe similar processes being
regulated in a timely manner, conferring certain robustness to
these conclusions, since the global result would be taken into
account and not just each time point isolated.
Materials and Methods
Cells
Trypanosoma cruzi Dm28c [46] epimastigotes were cultured in
liver infusion tryptose (LIT) medium [47] supplemented with 10%
fetal bovine serum without agitation at 28uC. For in vitro
differentiation, epimastigotes were harvested from LIT medium
after 5 days of culture, by centrifugation at 7,000 g for 5 min at
20uC. They were incubated for 2 h at 28uC in TAU medium
(190 mM NaCl, 17 mM KCl, 2 mM MgCl2, 2 mM CaCl2,
8 mM phosphate buffer pH 6.0) at a density of 56108 parasites/
ml and then diluted 1:100 in TAU3AAG medium (TAU
supplemented with 10 mM l-proline, 50 mM l-sodium glutamate,
2 mM l-sodium aspartate, and 10 mM d-glucose) in tissue culture
flasks not exceeding 1 cm height of medium. Metacyclic
trypomastigotes were purified from cell culture supernatants by
DEAE-cellulose chromatography after 72 h of incubation at 28uC
[48].
T. cruzi epimastigotes were grown in vitro until they reached
early stationary phase, stimulated to undergo metacyclogenesis
and collected at 5 time points during the process of differentiation:
Figure 2. Sequence windows used to extract phosphorylation
motifs. The sequence represents an example of the phosphorylated
region of a protein, showing the backbone structure of the different
window sizes used to extract phosphorylation motifs. The red letter
represents the phosphorylated residue (always centered), the blue
letters were emphasized to show the surrounding amino acids included
in each of the window sizes.
doi:10.1371/journal.pone.0025381.g002
Figure 3. Motifs found to have GO terms overrepresented.
doi:10.1371/journal.pone.0025381.g003
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for 30 minutes (St30m); cells submitted to nutritional stress for




8 epimastigotes forms and 1610
9 metacyclic
trypomastigotes) were washed three times in phosphate buffer
saline, pH 7.2 (8,000 g for 10 minutes at room temperature),
resuspended in 400 mL lysis buffer (7 M Urea, 2 M Thiourea,
1 mM DTT, 1% n-octylglucoside, 50 mM sodium fluoride,
10 mM sodium pyrophosphate, 1 mM sodium orthovanadate,
10 mM b-glicerophosphate, protease inhibitors (Amersham),
nuclease mix (Amersham)) and incubated with agitation for
30 minutes. The debris was removed by centrifugation and the
supernatants were collected and stored at 270uC until use.
Protein digestion
For in-solution digestion, protein extracts were reduced with
1 mM dithiothreitol, alkylated with 5.5 mM iodoacetamide,
digested for three hours with endoproteinase Lys-C (Waco),
diluted four times with 20 mM ammonium hydrogen carbonate
and further digested overnight with trypsin (Promega). A protease/
protein ratio of 1/50 was used for both enzymes. The peptide
digests were then submitted to TiO2 chromatography for
phosphopeptide enrichment and analyzed by LC-MS/MS as
described below.
TiO2 enrichment of phosphopeptides
Peptide digests were submitted to batch-wise enrichment of
phosphopeptides using TiO2 chromatography, as previously de-
scribed [49,50]. Briefly, TiO2 beads (GL Sciences) and samples were
pre-incubated with 2,5-dihydroxybenzoic acid (5 mg/mL final
concentration) in 80% acetonitrile. In each cycle of phosphopeptide
enrichment, TiO2 beads (approx. 1 mg) were added to the samples
and incubated for 30 minutes at room temperature, shaking at
1,000 rpm. After incubation, the beads were spun down, washed 2
times with 50% acetonitrile, 0.2% trifluoroacetic acid in water,
resuspended in washing buffer, loaded onto a RP-C8 Stage-tip
column and washed one more time. Bound peptides were eluted
fromthe columnwith a 40% acetonitrile, 0.5% ammonium solution,
pH.10.5, concentrated to approximately 10 ml, reconstituted in
100 ml of 2% acetonitrile, 1% TFA in water, desalted using RP-C18
StageTip [51] columns and analyzed by mass spectrometry.
NanoLC-MS/MS analysis
Peptide mixtures were separated by online reversed-phase (RP)
nanoscale capillary liquid chromatography (nanoLC) and analyzed by
electrospray tandem mass spectrometry (ES MS/MS). The experi-
ments were performed with an Agilent 1100 nanoflow system
connected to an LTQ-Orbitrap mass spectrometer (Thermo)
equipped with a nanoelectrospray ion source (Proxeon Biosystems).
Binding and chromatographic separation of the peptides took place in
a 15 cm fused silica emitter (75 mm inner diameter) in-house packed
with reversed-phase ReproSil-Pur C18-AQ 3 mmr e s i n( D r .M a i s c h
Table 3. GO enrichment analysis of phosphorylated proteins across metacyclogenesis.
GO Term Name Type FDR (,0.05) # Ph # Genome X
Epimastigostes
GO:0005509 calcium ion binding F 1.40E-02 10 81 4.00
GO:0004672 protein kinase activity F 1.40E-02 23 317 2.44
GO:0006464 protein modification process P 3.60E-02 35 633 1.89
Stress 30 minutes
GO:0003824 calcium ion binding F 9.00E-03 10 81 4.62
Stress 2 hours
GO:0004672 protein kinase activity F 1.60E-02 21 319 2.73
GO:0005509 calcium ion binding F 4.80E-02 8 83 3.79
Adhered 12 hours
GO:0005856 Cytoskeleton C 2.30E-03 18 242 3.24
GO:0004672 protein kinase activity F 5.90E-05 25 315 3.62
GO:0005509 calcium ion binding F 6.40E-03 9 82 4.59
GO:0000166 nucleotide binding F 7.90E-03 51 1292 1.89
GO:0003774 motor activity F 2.30E-02 10 130 3.21
GO:0006464 protein modification process P 6.60E-03 31 637 2.20
Metacyclic
GO:0005856 Cytoskeleton C 9.00E-04 21 239 3.00
GO:0004672 protein kinase activity F 4.10E-05 29 311 3.31
GO:0005509 calcium ion binding F 5.10E-04 12 79 5.05
GO:0000166 nucleotide binding F 1.60E-02 60 1283 1.71
GO:0003774 motor activity F 3.20E-02 11 129 2.79
GO:0006464 protein modification process P 4.30E-03 37 631 2.07
F, molecular function; C, cellular component; P, biological process; FDR, False Discovery Rate; # Ph, number of phosphorylated proteins ; # Genome, number of
proteins present in the genome; X, enrichment of each GO term.
doi:10.1371/journal.pone.0025381.t003
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injected onto the column with a flow of 500 nL/min and subsequently
eluted with a flow of 250 nL/min from 5% to 40% MeCN in 0.5%
acetic acid, in an 80 or 120 min gradient. The mass spectrometer was
operated in data dependent mode to automatically switch between
MS and MS/MS (MS2) acquisition. Survey full scan MS spectra
(from m/z 300–1600) were acquired in the Orbitrap analyzer with
resolution R=60,000 at m/z 400 (after accumulation to a target value
of 1,000,000 in the linear ion trap). The 5–10 most intense ions were
sequentially isolated and fragmented in the linear ion trap using
collisionally induced dissociation at a target value of 10,000. Former
target ions selected for MS/MS were dynamically excluded for
30 seconds. Total cycle time was of approximately three seconds. The
general mass spectrometric conditions were: spray voltage, 2.4 kV; no
sheath and auxiliary gas flow; ion transfer tube temperature, 100uC;
collision gas pressure, 1.3 mTorr; normalized collision energy using
wide-band activation mode; 35% for MS2. Ion selection thresholds
were: 250 counts for MS2. An activation q=0.25 and activation time
of 30 ms was applied in MS2 acquisitions. Multistage activation was
enabled in all MS/MS events to improve fragmentation spectra of
phosphopeptides and the ‘‘lock mass’’ option was enabled in all full
scans to improve mass accuracy of precursor ions.
Data processing and validation
Proteins were identified by automated database searching
(Mascot Daemon, Matrix Science) against a T. cruzi protein
sequence database, containing 19,615 protein sequences down-
loaded from GeneDB, http://www.genedb.org/) and a ‘decoy
database’, prepared by sequence reversing each entry of the amino
acid sequence from the genome annotation. This database was
complemented with frequently observed contaminants (porcine
trypsin, Achromobacter lyticus lysyl endopeptidase and human
keratins) and their reversed sequences as well. Search parameters
specified a MS tolerance of 5 ppm, a MS/MS tolerance at 0.5 Da
and full trypsin specificity, allowing for up to three missed cleavages.
Carbamidomethylation of cysteine was set as a fixed modification
and oxidation of methionines, N-terminal protein acetylation and
N-pyroglutamate were allowed as variable modifications. The peak
list generation for Mascot searches, as well as protein validation,
protein grouping and phosphosite localization, were done using
MaxQuant [26]. The FDRs were calculated based on the number
of reverse hits from the searches against the decoy database.
Peptides were required to have at least 6 amino acids in length, and
a FDR of 0.01 was applied at the levels of peptides, proteins and
phosphorylation sites. As described previously, a separate FDR
calculation is necessary for substoichiometric modifications (e.g.
phosphotyrosines), decreasing false positives and therefore avoiding
overestimating the occurrence of such modifications in the sample
[28]. This calculation is incorporated at MaxQuant platform. Only
the phosphorylation sites PTM with a score higher than 0.75 and a
delta score higher than 5 were considered. The comparison against
the data described here and the publication from Nakayasu was
done using only the phosphorylation sites that have been localized
by that paper for just one position.
To make our data accessible to the scientific community, we
uploaded our study to the data repositories PHOSIDA [52]
(http://www.phosida.org), Proteome Commons (https://www.
proteomecommons.org) and TriTrypDB (http://www.tritrypdb.
org), enabling researchers to access information about the
phosphorylation sites identified here.
Motif extraction
With the exact localization of serine/threonine phosphorylation
sites, the Motif-X algorithm [44] was used to extract phosphor-
ylation motifs. As input data to Motif-X, files containing S/T with
11 to 35 amino acids window for each phosphorylation position
were created. The set up used was based on 1E-6 stringency value,
20 occurrences, with the size adjusted for each sequence window
set, centralizing the specific phosphorylated amino acid. To be
used as background for the statistical calculations, the redundancy
of the T. cruzi genome had to be analyzed. A file containing 19,615
protein sequence entries resulted in 13,525 entries, which were
derived from a graphic clusterization by flow simulation using the
algorithm MCL with an inflation of 1.835. The tyrosine
phosphorylated sites were not used for this analysis since the
number of identified sites is similar to the occurrences.
GO enrichment analysis
To perform statistical analysis for overrepresentation of Gene
Ontology (GO) terms on the test sets we used the Blat2GO [45],
using the Fisher’s test with an FDR of 0.05 and looking for the
most specific terms.
Supporting Information
Figure S1 Proportion of residues located in loops.
Proportion of phosphorylated (red) and non-phosphorylated (blue)
serines, threonines and tyrosines that are located in loops,
according to secondary structure prediction. The phosphorylated
residues are significantly higher localized in loops and turns when
compared with their non-phosphorylated counterparts.
(TIFF)
Figure S2 S/T/Y average accessibility. Average accessi-
bility of phosphorylated (red) and non-phosphorylated (blue)
serines and threonines according to secondary structure predic-
tion. The predicted average accessibilities of T. cruzi phosphory-
lation sites were found to be significantly higher than the
accessibilities of non-phosphorylated sites.
(TIFF)
Figure S3 Phosphoproteome similarity on all domains
of life. Homologs of all T. cruzi proteins were derived and the
conservation of non-phosphorylated (blue) and phosphorylated (red)
proteins were accessed across a range of both prokaryotic and
eukaryotic organisms. When compared to other eukaryotic species,
t h ep e r c e n t a g eo fT. cruzi phosphorylated proteins that have homologs
is significantly higher than that of the non-phosphorylated proteins.
On the other hand, in the prokaryotic domain, phosphorylated T.
cruzi proteins are as conserved as the non-phosphorylated ones.
(TIFF)
Figure S4 Protein phosphorylation distribution. Proteins
were binned according to their number of phosphorylation sites, as
determined by LC-MS/MS. Bars represent the number of
proteins belonging to each category bin (red) and the summed
number of phosphorylation sites derived from the proteins in each
respective class (blue).
(TIFF)
Figure S5 Peptide phosphorylation distribution. Peptides
were binned according to their number of phosphorylation sites, as
determined by LC-MS/MS. Bars represent the number of non-
redundant phosphorylated peptides belonging to each category
bin (red) and the total number of MS/MS spectra identifying the
phosphopeptides of the corresponding bin (blue).
(TIFF)
Table S1 Proteins identified. Proteins identified and ordered
by phosphorylation presence.
(XLS)
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tion for each phosphorylation site identified. The informations are:
IDs for each protein group; proteins descriptions; position of the
phosphorylation at each protein; phosphorylated amino acid;
localization probabilities for each site; scores for the identification;
best protein kinase motif and its match probability; sequences with
probabilities and scores; for each site; peptide charge; mass to
charge; presence (‘‘+’’) or absence (‘‘ ’’) at the Trypanosoma cruzi
time points.
(XLS)
Table S3 Phosphorylated protein kinases. Description of
protein kinases found phosphorylated.
(XLS)
Table S4 Description of phosphorylation site motifs.
Detailed stratification of the numbers of phosphorylation sites
grouped at each window size and motif.
(XLS)
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